Intratumoral Injection of Ad-Isf35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression
Human Gene Therapy - United States
doi 10.1089/hum.2014.015
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
Mary Ann Liebert Inc